First 3D-Printed Drug Just Unveiled—Welcome to the Future of Medicine

obat-dari-printer-3dThere’s no question that 3D printing is going to change the world. From manufacturing to design, medicine to electronics, the technology has made significant leaps in terms of production—making what was once expensive and inaccessible, now cost efficient and available to many.

This almost makes Aprecia Pharmaceuticals’ announcement unsurprising. According to Science News Journal, Aprecia has become the first pharmaceutical brand in the world to use 3D printing technology to produce a drug called Spritam—a drug meant to treat epilepsy.

Not only was the drug successfully printed, it also managed to receive the necessary US FDA approval—and it’s now currently available in the United States.

READ THE REST HERE

About Peter Coffaro 1149 Articles

A growth-driven and strategic executive, Peter Coffaro commands more than 20 years of progressive management success within the medical device industry. As a District Sales Manager for Stryker Orthopaedics, Peter was responsible for managing and directing a regional sales force to achieve sales and profit goals within the Rocky Mountain region. Previously, he was the Director of Sales & Marketing for Amp Orthopedics. In this role, Peter was responsible for planning, developing, and leading all sales and marketing initiatives. Peter is a former orthopedic distributor in the Pacific Northwest. He has also worked with DePuy Orthopaedics as well as Zimmer, and held positions in sales, sales training, and sales management. Peter has an extensive background in organizational development, business development, sales management, negotiating and P&L management. Peter holds a B.S. degree in Biology from Northern Illinois University.

Be the first to comment

Leave a Reply

Your email address will not be published.


*